These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 18178976)

  • 1. Pneumocystis pneumonia in a person with a low CD4 count after stopping antiretroviral therapy.
    Ball SC
    AIDS Read; 2007 Dec; 17(12):583-6, 593. PubMed ID: 18178976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
    ; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
    Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia.
    Lee WS; Hsueh PR; Hsieh TC; Chen FL; Ou TY; Jean SS
    J Microbiol Immunol Infect; 2017 Aug; 50(4):547-548. PubMed ID: 27094385
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumocystis carinii pneumonia: a review of current issues in diagnosis and management.
    Barry SM; Johnson MA
    HIV Med; 2001 Apr; 2(2):123-32. PubMed ID: 11737389
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumocystis infection in humans: diagnosis and treatment.
    Calderón EJ; Gutiérrez-Rivero S; Durand-Joly I; Dei-Cas E
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):683-701. PubMed ID: 20521896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuing Pneumocystis carinii prophylaxis.
    Girard PM
    N Engl J Med; 2001 Jan; 344(3):222-3. PubMed ID: 11172146
    [No Abstract]   [Full Text] [Related]  

  • 8. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
    Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
    N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 10. Withdrawal of prophylaxis against Pneumocystis carinii pneumonia.
    Feinberg J
    Lancet; 1999 Apr; 353(9161):1287. PubMed ID: 10218521
    [No Abstract]   [Full Text] [Related]  

  • 11. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
    Mammen-Tobin A; Monteiro EF
    Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
    [No Abstract]   [Full Text] [Related]  

  • 12. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
    Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza PL; Rickenbach M; Flepp M; Malinverni R
    N Engl J Med; 1999 Apr; 340(17):1301-6. PubMed ID: 10219064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of primary Pneumocystis carinii prophylaxis after reconstitution of CD4 cell counts in HIV-infected children.
    Urschel S; Schuster T; Dunsch D; Wintergerst U; Hofstetter R; Belohradsky BH
    AIDS; 2001 Aug; 15(12):1589-91. PubMed ID: 11504999
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.
    Lim L ; Street AC; Lewin SR
    AIDS; 2001 Sep; 15(14):1912-3. PubMed ID: 11579267
    [No Abstract]   [Full Text] [Related]  

  • 15. Maintenance of chemoprophylaxis against Pneumocystis carinii despite combination antiretroviral treatment associated CD4+ T-lymphocytosis.
    Macher AM; Goosby EP
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1491. PubMed ID: 9105103
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pneumocystis infections].
    Aoki T; Oka S
    Med Mycol J; 2012; 53(1):13-7. PubMed ID: 22467126
    [No Abstract]   [Full Text] [Related]  

  • 17. Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection. HIV Outpatient Study (HOPS) Investigators.
    Yangco BG; Von Bargen JC; Moorman AC; Holmberg SD
    Ann Intern Med; 2000 Feb; 132(3):201-5. PubMed ID: 10651600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based practice: Management of combined toxoplasma meningo-encephalitis and Pneumocystis pneumonia in HIV.
    Bruck PE; Das S; Allan PS
    Virulence; 2010; 1(4):350-2. PubMed ID: 21178468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis.
    Degen O; ven Lunzen J; Horstkotte MA; Sobottka I; Stellbrink HJ
    AIDS; 2002 Jul; 16(10):1433-4. PubMed ID: 12131226
    [No Abstract]   [Full Text] [Related]  

  • 20. Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.
    Esposito S; Bojanin J; Porta A; Cesati L; Gualtieri L; Principi N
    Pediatr Infect Dis J; 2005 Dec; 24(12):1117-20. PubMed ID: 16371882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.